Published on 27 November 2025
Description:
ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains
Categories:
Pharmaceutical Market EuropePreview:
33 articles from this collection:
PME November 2025
2 PME MAGAZINE
3 Comment
4 Communique Awards 2025
5 Contents
6 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
10 Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
11 Dermatology News
12 DARWIN'S MEDICINE - Why bad habits are sabotaging your strategic decisions
The evolutionary lessons for Bayer’s management restructure
13 MIKE DIXON - Patient insight: human vs AIHCPs
Collecting the right data in the right way for the right reasons
14 INNOVATIVE IMPACT BLOG - Unlocking the full potential of healthcare company partnerships
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 HEALTHCARE: The trust crisis: how pharma must evolve to engage Gen Z HCPs
16-18 ESMO 2025 - ESMO 2025 – ensuring innovation isn’t lost in translation
Across almost every sector, brands are multiplying their investment in creativity
19 TL IPG HEALTH - Younger, not invisible: rewriting cancer care – starting with the pancreas
20-22 CLINICAL PATHWAYS - Optimised therapy to improve outcomes for heart attack and stroke patients
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
23 TL HAVAS LYNX - Reimagining pharma CX: three game-changing products driving human-centric innov
Picking your omnichannel direction requires a disciplined, scientific approach
23 FLYPHARMA
24-25 GLOBAL DRUG PRICING - Bridging the affordability gap
26 TL ASPIRE - The building of Aspire Pharma and values
27 TL EDELMAN - When populism meets public health: trust under siege
28-29 GLOBAL REGULATORY STANDARDS - Global regulatory standards
30 TL POP HEALTH - The most overlooked KPI in business? Joy
31 TL SYNERGY VISION - The new era of medical affairs: busting myths and supercharging strategic val
32-34 THE OMNICHANNEL ORCHESTRA - Setting out – why omnichannel success is about orchestration
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
35 TL UNIPHAR - Agility in medical affairs: responding to rapid market and regulatory shifts
36 Appointments
37 Appointments
38 ALS DISEASE - New research shows successful ALS treatment could be worth billions
39 SAMEDAN
40 EHP AWARDS 2026
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services